相似文献
1
A series of novel, highly potent and selective agonists for the kappa-opioid receptor.
Br J Pharmacol. 1990 Dec;101(4):944-8. doi: 10.1111/j.1476-5381.1990.tb14185.x.
2
GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activity.
Br J Pharmacol. 1992 Aug;106(4):783-9. doi: 10.1111/j.1476-5381.1992.tb14413.x.
3
Profile of activity of kappa receptor agonists in the rabbit vas deferens.
Eur J Pharmacol. 1985 Apr 16;110(3):317-22. doi: 10.1016/0014-2999(85)90558-8.
4
A novel series of potent and selective agonists at the opioid kappa-receptor.
Eur J Pharmacol. 1988 Jul 14;151(3):475-8. doi: 10.1016/0014-2999(88)90546-8.
5
CI-977, a novel and selective agonist for the kappa-opioid receptor.
Br J Pharmacol. 1990 Sep;101(1):183-9. doi: 10.1111/j.1476-5381.1990.tb12110.x.
6
DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity.
J Pharmacol Exp Ther. 2003 Dec;307(3):1221-6. doi: 10.1124/jpet.103.054361. Epub 2003 Oct 8.
7
Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
J Med Chem. 1998 Jul 16;41(15):2872-81. doi: 10.1021/jm980083i.
8
Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
J Pharmacol Exp Ther. 1990 Mar;252(3):1324-30.
9
The mu, kappa and delta properties of various opioid agonists.
Eur J Pharmacol. 1986 Apr 29;123(3):357-61. doi: 10.1016/0014-2999(86)90709-0.
10
Characterization of rabbit ear artery opioid receptors using a delta-selective agonist and antagonist.
Eur J Pharmacol. 1987 Jul 2;139(1):61-6. doi: 10.1016/0014-2999(87)90497-3.
引用本文的文献
1
Ligand and G-protein selectivity in the κ-opioid receptor.
Nature. 2023 May;617(7960):417-425. doi: 10.1038/s41586-023-06030-7. Epub 2023 May 3.
2
Synthesis and Pharmacological Evaluation of Fluorinated Quinoxaline-Based κ-Opioid Receptor (KOR) Agonists Designed for PET Studies.
ChemMedChem. 2020 Oct 5;15(19):1834-1853. doi: 10.1002/cmdc.202000502. Epub 2020 Sep 1.
3
A Survey of Molecular Imaging of Opioid Receptors.
Molecules. 2019 Nov 19;24(22):4190. doi: 10.3390/molecules24224190.
4
Development and In Vivo Evaluation of a κ-Opioid Receptor Agonist as a PET Radiotracer with Superior Imaging Characteristics.
J Nucl Med. 2019 Jul;60(7):1023-1030. doi: 10.2967/jnumed.118.220517. Epub 2019 Jan 10.
5
Opioidergic projections to sleep-active neurons in the ventrolateral preoptic nucleus.
Brain Res. 2008 Dec 15;1245:96-107. doi: 10.1016/j.brainres.2008.09.043. Epub 2008 Sep 24.
6
Functional evidence for multiple receptor activation by kappa-ligands in the inhibition of spinal nociceptive reflexes in the rat.
Br J Pharmacol. 1993 Sep;110(1):303-9. doi: 10.1111/j.1476-5381.1993.tb13809.x.
7
Central and peripheral actions of the novel kappa-opioid receptor agonist, EMD 60400.
Br J Pharmacol. 1994 Mar;111(3):843-51. doi: 10.1111/j.1476-5381.1994.tb14815.x.
8
Sensory nerve-mediated relaxation of guinea-pig isolated pulmonary artery: prejunctional modulation by alpha 2-adrenoceptor agonists but not sumatriptan.
Br J Pharmacol. 1993 May;109(1):126-30. doi: 10.1111/j.1476-5381.1993.tb13541.x.
9
Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist.
Br J Pharmacol. 1991 Jul;103(3):1819-23. doi: 10.1111/j.1476-5381.1991.tb09869.x.
10
GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activity.
Br J Pharmacol. 1992 Aug;106(4):783-9. doi: 10.1111/j.1476-5381.1992.tb14413.x.
本文引用的文献
1
Some quantitative uses of drug antagonists.
Br J Pharmacol Chemother. 1959 Mar;14(1):48-58. doi: 10.1111/j.1476-5381.1959.tb00928.x.
2
Determination of receptors that mediate opiate side effects in the mouse.
Br J Pharmacol. 1983 Jul;79(3):731-6. doi: 10.1111/j.1476-5381.1983.tb10011.x.
3
A kappa opioid effect: increased urination in the rat.
J Pharmacol Exp Ther. 1983 Jan;224(1):89-94.
4
Rabbit vas deferens: a specific bioassay for opioid kappa-receptor agonists.
Eur J Pharmacol. 1981 Jul 17;73(2-3):235-6. doi: 10.1016/0014-2999(81)90098-4.
5
The opioid kappa-selective compound U-50,488H does not inhibit intestinal propulsion in rats.
J Pharm Pharmacol. 1984 May;36(5):343-4. doi: 10.1111/j.2042-7158.1984.tb04391.x.
6
U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
J Pharmacol Exp Ther. 1983 Jan;224(1):7-12.
7
Effects of full and partial kappa agonists and mu agonists on urine output of normally hydrated rats.
Neuropeptides. 1984 Dec;5(1-3):283-6. doi: 10.1016/0143-4179(84)90083-0.
8
Effects of the highly selective kappa opioid, U-50, 488, on renal function in the anesthetized dog.
J Pharmacol Exp Ther. 1984 Sep;230(3):641-5.
9
Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
J Pharmacol Exp Ther. 1984 Aug;230(2):341-8.
10
Evaluation of the receptor selectivities of opioid drugs by investigating the block of their effect on urine output by beta-funaltrexamine.
J Pharmacol Exp Ther. 1987 Mar;240(3):984-8.
Zotero 插件